Press Releases
Hogan Lovells advises IMACTIS on its acquisition by GE HealthCare
10 January 2023
Matthieu Grollemund
PartnerParis
Email [email protected]hoganlovells.com
Phone +33 1 53 67 47 47
LanguagesEnglish, French, German
Practice groupCorporate & Finance
"He has knowledge of legal matters on both sides of the Atlantic, which makes things much easier."
Chambers Global 2018
Matthieu Grollemund is a Corporate partner in our Paris office and the global Private Equity leadership team.
Triple qualified in French, US and UK law, Matt Grollemund is a seasoned corporate lawyer with +20 years of experience in complex and cross-border transactions. He represents private equity sponsors, venture capital firms, public and private corporations, boards of directors and special committees in their most sensitive investments, public and private M&A transactions, IPOs, amicable or defense against hostile transactions. He is particularly known in the Tech and Healthcare industries, with unparalleled track record in France.
Prior to joining the firm, Matthieu Grollemund was Co-Head of the Paris Corporate Department of an international law firm. He also spent five years as a partner in a US-based global law firm in the New York office.
Awards and recognitions
2022
Europe most innovative lawyers
Financial Times
2021
Corporate/M&A (France)
Chambers Global
2020-2021
Lawyers specialised in LBOs (transactions on companies worth more than €300m) and innovation capital
Option Droit & Affaires
2020
Ranked Individuals “Private Equity: Venture Capital in France”
Chambers Europe
2017
Foreign Expert in Corporate/M&A (France and UK)
Chambers Global
Education and admissions
Education
Corporate Law, University of Paris I Panthéon-Sorbonne, 1997
M.B.A., ESCP Paris, 1995
Bar admissions and qualifications
Paris
Solicitor, England and Wales
Licensed as a Foreign Legal Consultant, New York
Representative experience
Advised on numerous major French tech transactions (Doctolib, Mirakl, Ynsect, Ledger, ManoMano, Contentsquare, Sorare, Exotec, Blablacar, Dataiku, FarFetch, Back Market, PayFit, Lydia, Criteo)
Advised on a number of IPO and international offerings (AAA, Criteo, Navya, Farfetch)*
Advised numerous tender of offers and Public M&A (Zimmer Biomet on Medtech, Medtronic on Medicrea, Stryker on Vexim, Aptar on Voluntis)
Advised on the acquisition by Arch of a 30% block in Coface*
Advised Tencent on the acquisition of a minority interest in Ubisoft from Vivendi*
Advised ADM in the acquisition of Neovia from Invivo and Eurazeo for €1.4bn*
Advised in the disposition of Maesa to Bain Capital*
Routinely advises a number of private equity funds on their growth and LBO investments mostly in the Tech, Life Science, Fintech and highly regulated industries*
*Matter handled prior to joining Hogan Lovells.
Latest thinking and events
Press Releases
Hogan Lovells advises Artémis Group, the Pinault family's holding company, on the merger of Artémis Domaines with Maisons & Domaines Henriot
03 October 2022
Press Releases
Hogan Lovells advises Cryptosense on its acquisition by SandboxAQ
15 September 2022
Press Releases
Hogan Lovells advises Hauck Aufhäuser Lampe Privatbank AG on acquisition of Hella GmbH & Co. KGaA by Faurecia SE
25 February 2022
Awards and Rankings
Stephane Huten named 2021 Private Equity Lawyer of the Year in French business law magazine Option Droit & Affaires
13 January 2022
Press Releases
Hogan Lovells advises 83north, Bain Capital, Elaia and Felix Capital on Mirakl's $555 million Series D
22 September 2021
